A Trial of Cardiac Injections of iMP Cells During CABG Surgery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT03515291

Recruitment Status : Unknown

Verified January 2020 by Cell Therapy Ltd..
Recruitment status was: Not yet recruiting

First Posted : May 3, 2018

Last Update Posted : January 27, 2020

Sponsor:

Collaborator:

Royal Brompton & Harefield NHS Foundation Trust

Information provided by (Responsible Party):

Cell Therapy Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	January 2021
Estimated Study Completion Date :	July 2021

Publications:

Anastasiadis K, Antonitsis P, Westaby S, Reginald A, Sultan S, Doumas A, Efthimiadis G, Evans MJ. Implantation of a Novel Allogeneic Mesenchymal Precursor Cell Type in Patients with Ischemic Cardiomyopathy Undergoing Coronary Artery Bypass Grafting: an Open Label Phase IIa Trial. J Cardiovasc Transl Res. 2016 Jun;9(3):202-213. doi: 10.1007/s12265-016-9686-0. Epub 2016 Apr 1. Erratum in: J Cardiovasc Transl Res. 2021 Jun;14(3):587-588.

To Top